slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 42,391-42,420
Pages 10,126
Rows per page 30
Component
42,391-42,420 of 303,780
35
The slide presents two line/box plots showing dose-dependent responses to stabilised adenosine.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
36
The slide presents two key clinical data plots: a pharmacodynamic correlation (exposure vs inhibition) and a pharmacokinetic profile (concentration over time).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
38
The slide outlines a standard oncology clinical trial design (Dose Escalation to RP2D to Dose Expansion).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
39
The slide uses a human anatomy diagram to map specific cancer types to their respective incidence numbers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
40
Includes a biological pathway diagram and a honeycomb-style indication map.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
41
The slide uses a three-column layout to define the target product profile (TPP) requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
42
The table uses a color-coded system (green/yellow/red) to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
43
Data source: Besnard et al, AACR (2022).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
44
The waterfall plot shows drug response scores across many samples, indicating sensitivity. The right side summarizes findings and the rationale for combination testing.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
45
The slide uses a heatmap to display binary synergy results (Yes/No) across three drug combinations, alongside a bar chart showing single-agent sensitivity.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
46
The slide uses a Venn diagram to illustrate the overlap of gene modulation between peripheral blood and primary tumours, and line charts to show dose-response curves for two specific biomarkers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
48
TPP stands for Target Product Profile.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
49
The slide uses a traffic-light color coding system to highlight performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
50
The slide uses a process-flow layout to describe the company's R&D methodology.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
52
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
53
Includes two scientific diagrams illustrating the mechanism of action and brain penetration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
54
The slide uses a three-column layout to define technical requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
55
The slide uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
56
The slide uses a linear process framework to explain the drug discovery pipeline.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
57
The slide uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting the selection of 'unattractive' compounds.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
58
The slide shows two charts: a line chart for tumour volume over time and a dot plot for plasma Pro-GRP concentration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
59
The slide uses two distinct chart types (dot plot and line chart) to demonstrate the safety profile of a reversible inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
60
The chart shows a statistically significant difference (****) between the vehicle control and the treatment groups.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
61
The slide uses a two-column layout to contrast PK data with Toxicology/Safety data.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
62
The slide uses a split-layout to contrast current operational status with high-level program benefits.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
64
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
65
Scientific/medical context slide explaining a therapeutic target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
66
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
67
The slide uses a scientific mechanism-of-action argument to establish a competitive moat.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits
68
The slide uses a heatmap-style table to compare the company's asset against competitors, with a specific callout box around the UGT1A1 row.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 2 hits